The use of multi-gene panels or whole-exome/genome sequencing as first line of genetic diseases diagnosis will bring out an increasing number of exonic and intronic APOB variants of uncertain significance in patients with either hypobetalipoproteinemia or hypercholesterolemia [37,38]. The gene discussed is APOB; the disease is hypobetalipoproteinemia.